Table 2 Pre- and Post-IARC 2007 studies of shift work and cancer: Targeted assessment of chronotype, internal time, or circadian disruption
Publication | Targeted assessment | ||||
|---|---|---|---|---|---|
First author, year | Cancer Endpoint | Chronotype/Chronobiological propensity | Biological day or Biological night | Circadian disruption | |
At work | Off work | ||||
Pre-IARC | |||||
Tynes, 1996 [56] | Breast | – | – | – | – |
Davis, 2001 [57] | Breast | – | – | – | – |
Hansen, 2001 [58] | Breast | – | – | – | – |
Schernhammer, 2001 [59] | Breast | – | – | – | – |
Schernhammer, 2003 [60] | Colorectum | – | – | – | – |
Lie, 2006 [61] | Breast | – | – | – | – |
O’Leary, 2006 [62] | Breast | – | – | – | – |
Schernhammer, 2006 [63] | Breast | – | – | – | – |
Kubo, 2006 [64] | Prostate | – | – | – | – |
Schwartzbaum, 2007 [65] | Cancer | – | – | – | – |
Viswanathan, 2007 [66] | Endometrium | – | – | – | – |
Conlon, 2007 [67] | Prostate | – | – | – | – |
Post-IARC | |||||
Lahti, 2008 [68] | Non-Hodgkin | – | – | – | – |
Pukkala, 2009 [69] | Cancer | – | – | – | – |
Pesch, 2010 [70] | Breast | – | – | – | – |
Pronk, 2010 [71] | Breast | – | – | – | – |
Kubo, 2011 [72] | Prostate | – | – | – | – |
Schernhammer, 2011 [73] | Skin | – | – | – | – |
Lie, 2011 [74] | Breast | – | – | – | – |
Hansen, 2012a [34] | Breast | Yes | – | – | – |
Hansen, 2012b [75] | Breast | – | – | – | – |
Parent, 2012 [76] | Cancer | – | – | – | – |
Knutsson, 2013 [77] | Breast | – | – | – | – |
Menegaux, 2013 [78] | Breast | – | – | – | – |
Rabstein, 2013 [79] | Breast | – | – | – | – |
Bhatti, 2013 [35] | Ovary | Yes | – | – | – |
Lin, 2013 [80] | Pancreas | – | – | – | – |
Grundy, 2013 [81] | Breast | – | – | – | – |
Fritschi, 2013 [36] | Breast | Yes | – | – | – |
Schernhammer, 2013 [82] | Lung | – | – | – | – |
Grundy, 2013 [83] | Breast | – | – | – | – |
Gapstur, 2014 [84] | Prostate | – | – | – | – |
Carter, 2014 [85] | Ovary | – | – | – | – |
Koppes, 2014 [86] | Breast | – | – | – | – |
Truong, 2014 [87] | Breast | – | – | – | – |
Yong, 2014 [88] | Cancer | – | – | – | – |
Rabstein, 2014 [89] | Breast | – | – | – | – |
Kwon, 2015 [90] | Lung | – | – | – | – |
Li, 2015 [91] | Breast | – | – | – | – |
Akerstedt, 2015 [92] | Breast | – | – | – | – |
Hammer, 2015 [93] | Prostate | – | – | – | – |
Papantoniou, 2015 [37] | Prostate | Yes | – | – | – |
Lin, 2015 [94] | Biliary tract | – | – | – | – |
Cordina-Duve., 2016 [95] | Breast | – | – | – | – |
Gyarmati, 2016 [38] | Stomach | Yes | – | – | – |
Papantoniou, 2016 [39] | Breast | Yes | – | – | – |
Travis, 2016 [11] | Breast | Yes | – | – | – |
Costas, 2016 | CLL | – | – | – | – |
Dickerman, 2016 [40] | Prostate | Yes | – | – | – |
Heckman, 2017 [41] | Skin | Yes | – | – | – |
Papantoniou, 2017 [96] | Colorectum | – | – | – | – |